News EPFL

Discovering the essence of Le Corbusier in his apartment-studio

Published:04.05.18 — How should an iconic piece of modern architecture be restored? Two EPFL researchers took up this challenge, tracing the history of Le Corbusier’s apartment-studio in Paris. They published their findings in a book, which includes restoration guidelines that draw on previously unpublished sources of information about the Swiss architect. The book launch will take place on 7 May at EPFL.

US group Agilent enters EPFL Innovation Park by acquiring Genohm

Published:02.05.18 — Genohm SA, which develops laboratory management solutions, will be bought by Agilent Technologies, a company listed on the New York Stock Exchange. The startup’s workforce – 20 employees and growing – will remain in the Lausanne region.

The 3rd Isabelle Musy Award goes to a 3D concrete printing startup

Published:02.05.18 — The winner of the 2018 Isabelle Musy Award is Agnès Petit, the founder of Mobbot, a startup that develops and markets 3D printing systems for concrete. The award and its CHF 50,000 cash prize will be given to Petit at a ceremony tonight at EPFL. With a rendering as smooth as if the concrete had been coffered.

Why public spaces in European cities are becoming homogenized

Published:01.05.18 — European public spaces are becoming more original, but also more homogeneous. The author of an architecture thesis, written at EPFL, explains this paradox and calls on critics and public authorities to do something about it.

Worms in high-tech housing replace laboratory mice

Published:01.05.18 — In an effort to improve drug, cosmetic and other chemical product tests, Nagi Bioscience has created a device that automatically grows, feeds, houses and analyzes laboratory worms. This invention will save researchers both time and money and sharply reduce the number of tests that require laboratory rondents. A prototype has already been tested and approved by several laboratories.

Double-bridged peptides bind any disease target

Published:30.04.18 — EPFL scientists have developed a new type of "double-bridged peptide" that can be tailored to bind tightly to disease targets of interest. The peptides’ highly efficient binding, combined with their small size and high stability make them ideal for drug therapies. The work is published in Nature Chemistry.

Kung Fu Sets ArtLab in motion

Published:27.04.18 — The exhibition Kung Fu Motion: The Living Archive opens tomorrow, on Saturday April 28. It accompanies the integration of ArtLab into EPFL’s College of Humanities and kicks off a stimulating series of fresh programs at the intersections of art/science.